OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Chemotherapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis	70
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam	48
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA2	31
Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement	30
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer	22
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem	21
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae	17
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis	13
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma	13
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer	12
YAP/TAZ axis was involved in the effects of metformin on breast cancer	12
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database	11
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients	10
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin	9
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study	9
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics	9
Combination therapy of sotorasib and docetaxel overcomes resistance to sotorasib alone in KRAS G12C mutant lung adenocarcinoma	9
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms	9
Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma	9
A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic cours	8
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade	8
Early daratumumab-based therapy demonstrates significant effectiveness in patients with relapsed and refractory multiple myeloma: a real-world retrospective investigation	8
The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient	8
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma	8
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer	8

Reversible chemoresistance of pancreatic cancer grown as spheroids	8
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals	8
Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs	8
Genetic landscape and therapeutic evolution of cyclophosphamide: spotlight on breast cancer	7
Recent advances in polymer-based nanoparticles: current strategies and translational challenges in cancer therapy	7
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience	7
Advances in MUC1 resistance to chemotherapy in pancreatic cancer	7
Exploring the role of quercetin on doxorubicin and lapatinib-mediated cellular and mitochondrial responses using in vitro and in s	7
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer	7
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status	7
The role of maintenance therapy in the treatment of advanced urothelial cancer: a comprehensive systematic review and network meta-analysis	7
Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer	7
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital	7
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics	7
Cost-effectiveness analysis of dostarlimab plus chemotherapy versus pembrolizumab plus chemotherapy as first-line treatment of metastatic non-squamous non-small cell lun	6
Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study	6
Initial cumulative area under the blood concentration-time curve of vancomycin is associated with the incidence of acute kidney injury	6
Emerging role of competing endogenous RNA in lung cancer drug resistance	6
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells	6
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer	6
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway	6
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story	5
E2F1-induced transcriptional activation of MAL2 inhibits sunitinib sensitivity and promotes the malignant progression of bladder cancer	5
Novel SNX25-ROS1 fusion mutation confers therapeutic sensitivity to entrectinib: a case report and literature review	5
Short-term neurotoxicity trajectory in patients with thoracic cancers receiving triweekly albumin-bound paclitaxel	5
Erythema multiforme as a rare skin manifestation during pembrolizumab treatment: a case report and literature review	5
Comparison of Syrian generic ceftriaxone sodium preparations for injection: BHT content and its implications	5
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma	5
Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia	5
A case of ICIs-associated arthritis caused by Toripalimab initially presenting as oedema in both lower limbs	5
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations	4
Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia	4
Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin	4
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<	4
Successful treatment with oxaliplatin and programmed cell death protein 1 inhibitor in recurrent advanced endometrial carcinoma with mismatch repair defects: a case report and literature review	4
Furmonertinib activity in NSCLC Harbouring EGFR L858R and ERBB2 S310F co-mutations: a case report with literature review	4
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine	4
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells	4
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza	4
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey	4
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials	4
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study	4
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study	4
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes	4
Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes in breast cancer patients: a systematic review study	4
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses	4
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units	4
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report	4
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma	4
Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database	4

The tumor microenvironment: shaping cancer progression and treatment response	4
Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis	4
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways	3
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge	3
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients	3
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy	3
Implementation of effective strategies to prevent Candida auris transmission in a Quaternary Care Center, Riyadh, Saudi Arabia	3
Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma	3
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis	3
Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review	3
Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors	3
Liposome-assisted combination chemotherapy improves the anti-proliferation and anti-angiogenesis response of cisplatin in breast cancer; experimental and computational study	3
Varicella zoster virus reactivation reported with isatuximab use	3
Colistin resistance among the Gram-negative nosocomial pathogens in India: a systematic review and meta-analysis	3
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy	3
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2	3
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)	3
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer	3
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital	3
Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience	3
Cost-effectiveness analysis of pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer	3
LncRNA-IQCH-AS1 sensitizes thyroid cancer cells to doxorubicin via modulating the miR-196a-5p/PPP2R1B signalling pathway	3
Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma	3
Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms	3
Clinical features, treatments, and outcomes of atezolizumab-induced diabetes mellitus in cancer patients	3
Assessment of in vitro interactions between delafloxacin and other antimicrobials against multi-drug resistant Pseudomonas aeruginosa strains	3
Time to reconsider moxifloxacin anti-anaerobic activity?	3
Long-term outcomes of sequential chemotherapy in epithelioid sarcoma	3
Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression	3
NCAPG2 promotes the proliferation, metastasis and resistance to nab-paclitaxel in gastric adenocarcinoma cells	3
Docetaxel associated myositis	3
A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae	3
CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner	3